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CORRESPONDENCE
Subacute sclerosing panencephalitis 
still occurring in South Africa: 
Clinicians need to remain vigilant
To the Editor: We report on another child with subacute sclerosing 
panencephalitis (SSPE), expanding the case series reported by Kija et 
al.[1] to six affected children from the Western Cape region of South 
Africa (SA) diagnosed in the past 18 months. 
The child presented to Red Cross War Memorial Children’s Hospital, 
Cape Town, at 6 years and 3 months of age. She had recently returned to SA 
after living for several years in Zimbabwe. Her caregivers in SA had not seen 
her regularly, but understood that her previous health and development had 
been normal. She was admitted with a reported 1-day history of sudden-
onset weakness and abnormal movements. She had no known history of 
toxin exposure or prodromal symptoms prior to her presentation. She had 
neurodevelopmental regression and demonstrated emotional lability with 
incoherent speech and disorientation. She was not independently mobile. 
Her tone and power were normal and symmetrical with brisk deep tendon 
reflexes. Her abnormal movements were noted to be myoclonic jerks and 
atonic seizures which manifested as ‘head nods’. She was systemically well 
with no evidence of sepsis, and while HIV-exposed she had tested negative. 
Cerebrospinal fluid (CSF) microscopy and chemistry results were normal. 
An electroencephalogram (EEG) was initially slow with no epileptiform 
activity correlating with the jerks. Owing to concern about her dramatic 
presentation and apparent acute-onset encephalopathy, an emergency 
magnetic resonance imaging (MRI) scan of the brain was performed. This 
showed high signal on T2 and fluid attenuation inversion recovery (FLAIR) 
in the posterosuperior putamina, seen to a greater extent on the left than the 
right (Fig. 1). On the basis of this finding and the unusual clinical phenotype, 
SSPE was suspected. The child’s CSF measles IgG was positive, while CSF 
measles polymerase chain reaction (PCR) tested negative. 
The history of prior measles infection was not initially elicited from 
the main caregiver, but on further questioning it emerged that the child 
had contracted measles during the epidemic of 2009 while in SA. The 
further history unfolded that she had returned from Zimbabwe several 
months previously but into the care of a different family member. At this 
point it was confirmed that her symptoms were more chronic and she had 
been managed at Tygerberg Children’s Hospital, where SSPE had been 
diagnosed previously. The caregiver at the time was counselled regarding 
the diagnosis, but elected to remove the child and transferred her into the 
care of the current caregiver with no explanation of the preceding events – 
hence the precipitant presentation with the misleading history. 
A diagnosis of SSPE, stage two, was made and the child was 
initiated on carbamazepine and isoprinosine. Over the next 12 weeks 
her condition remained static with persistent myoclonic and atonic 
seizures. Serial EEGs, while detecting generalised epileptiform 
discharges, failed to correlate with the clinical events. Her level of 
awareness continued to fluctuate, but she has not regressed further. 
This case is similar to those reported by Kija et al.[1] in that the child 
contracted measles during the 2009 - 2011 epidemic, during the vulnerable 
period of infancy before her 9-month measles immunisation. While she 
was 2 years older at presentation than our previous cases, this is more 
in keeping with the internationally reported cases’ presenting age of 5  - 
17 years.[2] Her MRI findings included changes affecting the deep grey-
matter region, which although unusual have been reported in SSPE.[3,4] 
To date her clinical deterioration has been slower than in the other cases. [1] 
It is not known whether this is because she was initiated on isoprinosine 
relatively early in her course, or because she presented at an older age than 
the other SA children. As in the other reported cases, her measles PCR 
was negative, with CSF measles antibody titres confirming the diagnosis.
This additional case demonstrates that SSPE linked to the 2009 - 
2011 measles epidemic continues to occur in the Western Cape 
region. It is unclear why it has not been reported from other provinces 
of SA. Clinicians should have a high index of suspicion when a child 
presents with acquired movement disorders, intractable seizures 
and cognitive decline, especially those who were infants during the 
epidemic of 2009 - 2011. Furthermore, the history of measles may 
not be forthcoming initially, and clinicians may need to pursue this 
clinical entity in their workup in order to confirm the diagnosis. 
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Fig. 1. T2-weighted axial MRI scan of the brain at the level of the basal 
ganglia.
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